- Trials with a EudraCT protocol (680)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (126)
680 result(s) found for: Cellular.
Displaying page 6 of 34.
EudraCT Number: 2013-001005-82 | Sponsor Protocol Number: TALL/IP/2 | Start Date*: 2015-05-05 |
Sponsor Name:Galileo Research Srl | ||
Full Title: Phase II trial of intraperitoneal MHC unrestricted adoptive cell therapy with TALL-104 cells in patients with ovarian carcinoma with minimal or microscopic residual disease at second look laparotom... | ||
Medical condition: Ovarian carcinoma (FIGO stage IIIA and IIIB/IIIC/IV; patients with extra-abdominal disease will be excluded by the study unless those with pleural effusion) with minimal/microscopic residual disease. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: IT (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2019-003819-56 | Sponsor Protocol Number: 26193789 | Start Date*: 2020-06-12 | |||||||||||||||||||||
Sponsor Name:Centre for Surgical Science | |||||||||||||||||||||||
Full Title: Effects of intravenous administered iron in non-anemic iron deficient patients with colorectal cancer. A double blinded clinical randomized trial. | |||||||||||||||||||||||
Medical condition: Iron-deficiency in colorectal cancer | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DK (Trial now transitioned) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-000988-68 | Sponsor Protocol Number: O2021-1 | Start Date*: 2021-03-31 |
Sponsor Name: Region Stockholm | ||
Full Title: Immune response after covid-19 vaccination in patients with renal failure stadium 4 or 5 . | ||
Medical condition: Renal failure stage 4 and 5. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-005355-32 | Sponsor Protocol Number: IIV-275 | Start Date*: 2014-03-06 |
Sponsor Name:National Institute for Public Health and the Environment (RIVM, the Netherlands) | ||
Full Title: Memory response against Bordetella pertussis in adults: immunological effects of an acellular pertussis booster vaccination | ||
Medical condition: The vaccine administered in this study is used to prevent pertussis caused by the bacterium Bordetella pertussis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2022-002352-39 | Sponsor Protocol Number: APHP220580 | Start Date*: 2022-06-30 |
Sponsor Name:Assistance Publique – Hôpitaux de Paris (AP-HP) | ||
Full Title: Follow-up of Contact Persons at Risk of Monkeypox infection: prospective cohort study (MONKEY VAX) | ||
Medical condition: The research is proposed to people at risk of infection with the monkey pox virus (Monkey pox), and to whom an anti-pox vaccine is proposed according to the health authorities recommandations (JYNN... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2021-003573-58 | Sponsor Protocol Number: 2025 | Start Date*: 2021-08-09 |
Sponsor Name:Antwerp University Hospital | ||
Full Title: Vaccination against cOvid-19 In CancEr: booster shot BNT161b2 vaccine after full vaccination with ChAdOx1-S vaccine (Tri-VOICE plus) | ||
Medical condition: Onco-hematological patients | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2018-001238-16 | Sponsor Protocol Number: CNTO1959PSO3012 | Start Date*: 2019-01-03 | |||||||||||
Sponsor Name:Janssen-Cilag International NV | |||||||||||||
Full Title: A Phase 3b, Randomized, Double-blind, Active-controlled, Multicenter Study to Evaluate Further Therapeutic Strategies with Guselkumab in Patients with Moderate-to-Severe Plaque-Type Psoriasis | |||||||||||||
Medical condition: Moderate to Severe Plaque Type Psoriasis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Trial now transitioned) FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-001515-22 | Sponsor Protocol Number: S54226 | Start Date*: 2012-05-16 |
Sponsor Name:Katholieke Universiteit Leuven | ||
Full Title: Cytomegalovirus infection and the influenza vaccination response in older persons | ||
Medical condition: Humoral and cellular immune response after vaccination in older people | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-003803-30 | Sponsor Protocol Number: 2560/2008 | Start Date*: 2011-04-28 | ||||||||||||||||
Sponsor Name:AZIENDA OSPEDALIERA PISANA | ||||||||||||||||||
Full Title: Effects of the treatment with metformin and/or sitagliptin on β- cell function and insulin resistance in women with prior gestational diabetes. | ||||||||||||||||||
Medical condition: previous gestational diabetes | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: IT (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-002356-37 | Sponsor Protocol Number: VAX-TRES | Start Date*: 2021-09-22 | ||||||||||||||||
Sponsor Name:Fundació Clinic per a la Recerca Biomèdica (FCRB) | ||||||||||||||||||
Full Title: Study about the response to the administration of a third dose of mRNA-1273 vaccine (COVID19 vaccine Moderna) in renal transplants with immunological failure initial to vaccination | ||||||||||||||||||
Medical condition: COVID19 vaccine in kidney transplant patients | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-003116-22 | Sponsor Protocol Number: RBK091 | Start Date*: 2006-12-21 |
Sponsor Name:Prof. Sechtem, Department of Cardiology, Robert Bosch Hospital | ||
Full Title: Application of Sildenafil in patients with documented coronary vasospasm in order to explore the pathophysiology of coronary vasospasm and the therapeutic effects of Sildenafil in patients sufferin... | ||
Medical condition: Coronary vasospasm is an abrupt severe vasoconstriction of coronary arteries leading to myocardial ischemia and angina pectoris. The reason for the occurrence of coronary spasm and the cellular mec... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2004-004404-21 | Sponsor Protocol Number: SLE-Omega | Start Date*: 2004-12-10 |
Sponsor Name:GreenPark Healthcare Trust [...] | ||
Full Title: Omega-3-Polyunsaturated Fatty Acids and Atherosclerosis in Systemic Lupus Erythematosus: Cellular Mechanisms and Functional Consequences | ||
Medical condition: Systemic Lupus Erythematosus | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-002455-26 | Sponsor Protocol Number: IRON-CMR | Start Date*: 2014-09-20 |
Sponsor Name:Karolinska Institute | ||
Full Title: The use of intravenous Iron oxide as a contrast agent for cardiac magnetic resonance imaging. | ||
Medical condition: Cardiovascular diseases: Acute myocardial infarction, chronic myocardial infarction, myocardial ischemia, myocarditis, diffuse myocardial fibrosis. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-004529-57 | Sponsor Protocol Number: 06/AM/108 | Start Date*: 2008-09-08 |
Sponsor Name:Greenpark Healthcare Trust | ||
Full Title: Vascular Pleiotrophic Effects of Bisphosphonates in Post Menopausal Women with Osteoporosis: Cellular Mechanisms and Functional Consequences | ||
Medical condition: osteoporosis cardiovascular disease | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-002406-30 | Sponsor Protocol Number: 04/WNo02/9 | Start Date*: 2004-12-08 |
Sponsor Name:Conwy and Denbighshire NHS Trust [...] | ||
Full Title: Estimating glomerular filtration rate using measured muscle mass | ||
Medical condition: Chronic renal failure classified as stage 1-4 (mild impairment to pre-end stage renal disease, Levey et al., 2003) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-021435-14 | Sponsor Protocol Number: n.a. | Start Date*: 2010-12-06 |
Sponsor Name:Academisch Medisch Centrum Amsterdam | ||
Full Title: Effects of abatacept (Orencia®) on biomarkers in synovial tissue in patients with rheumatoid arthritis | ||
Medical condition: rheumatoid arthritis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-007276-41 | Sponsor Protocol Number: Ram_GEP_1 | Start Date*: 2008-05-13 |
Sponsor Name:Medizinische Universität Wien, Universitätsklinik für Klinische Pharmakologie | ||
Full Title: Gene expression profiling in skeletal muscle of healthy subjects treated with ramipril | ||
Medical condition: healthy young males | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-001640-56 | Sponsor Protocol Number: PI12/01866 | Start Date*: 2014-01-31 | |||||||||||
Sponsor Name:Fundación Para la Investigación Biomédica de Córdoba | |||||||||||||
Full Title: Crossover clinical trial, randomized, double blind, placebo controlled trial. Modulation of cellular mediators and repair endothelial damage in patients with chronic renal disease through inhibitio... | |||||||||||||
Medical condition: Patients with chronic kidney disease and asymptomatic hyperuricemia on the balance of mechanisms of vascular injury and repair. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-014770-17 | Sponsor Protocol Number: NVI-255 | Start Date*: 2009-10-09 |
Sponsor Name:Netherlands Vaccine Institute | ||
Full Title: New influenza A (H1N1) disease incidence and immunogenicity of the pandemic influenza A (H1N1) vaccine in healthy adults | ||
Medical condition: influenza A (H1N1) virus infection | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-001267-24 | Sponsor Protocol Number: UCA-12-EC/21/ALO | Start Date*: 2022-06-24 |
Sponsor Name:Arthroscopic Surgery Unit | ||
Full Title: Pilot study to evaluate intra-articular infiltrations of allogeneic Platelet Rich Plasma (PRP) for the treatment of knee osteoarthritis. | ||
Medical condition: Knee osteoarthritis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
